GILD Influence.. Yep Appendix A, Table 2. Panel
Post# of 148160
Appendix A, Table 2. Panel on COVID-19 Treatment Guidelines Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics (Reporting Period: May 1, 2019, to March 31, 2020)
Member Financial Disclosure
Company Relationship
Judith Aberg Gilead Sciences Research Support
Regeneron Research Support
Adaora Adimora Gilead Sciences Consultant, Research Support
Jason Baker Gilead Science Research Support
Roger Bedimo Gilead Sciences Honoraria
Pamela Belperio None N/A
John T. Brooks None N/A
Timothy Burges None N/A
Stephen Cantrill None N/A
Ann C. Collier None N/A
Craig Coopersmith None N/A
Page Crew None N/A
Eric Daar Gilead Sciences Consultant, Research Support
Richard T. Davey, Jr. None N/A
Susan L. Davis None N/A
Amy L. Dzierba None N/A
Laurie K. Doepel None N/A
Robert W. Eisinger None N/A
Laura Evans None N/A
Joseph Francis None N/A
Rajesh Gandhi Gilead Sciences Advisory Board
David Glidden Gilead Sciences Consultant
Birgit Grund None N/A
Roy M. Gulick None N/A
Erica J. Hardy None N/A
Elizabeth S. Higgs None N/A
Brenna L. Hughes None N/A
Steven Johnson None N/A
Arthur Kim None N/A
Marla J. Keller None N/A
Safia Kuriakose None N/A
H. Clifford Lane None N/A
Jeffrey L. Lennox
None
N/A
Andrea M. Lerner
None
N/A
Mitchell M. Levy
None N/A
Gregory Martin Regeneron Consultant
Henry Masur None N/A
Susanna Naggie AbbVie Research Support
Gilead Sciences Research Support
Vir Biotechnology Advisory Board, Stock Options
Martha C. Naso
None N/A
Alice K. Pau
None N/A
Nitin Seam None N/A
Virginia Sheikh None N/A
Steven Q. Simpson None N/A
Kanal Singh None N/A
Susan Swindells None N/A
Pablo Tebas Gilead Sciences Research Support
Inovio Pharmaceuticals Research Support
Phyllis Tien None N/A
Timothy Uyeki None N/A
Alpana A. Waghmare Ansun BioPharma Research Support
KYORIN Pharmaceutical Co. Advisory Board
Robert Walker None
N/A
Kevin C. Wilson None N/A
Read More: https://investorshangout.com/post/view?id=574...z6LIUAdFkK